Julia G. Butchko - 27 Jul 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Dev. & Tech. Officer
Signature: /s/ Eva Renee Barnett, attorney-in-fact for Julia G. Butchko
Issuer symbol: IMVT
Transactions as of: 27 Jul 2022
Transactions value $: -$2,178
Form type: 4
Filing time: 29 Jul 2022, 07:38:55 UTC
Previous filing: 01 Jul 2022
Next filing: 19 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Sale	-$2.18K	-510	-0.18%	$4.27^*	281K	27 Jul 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,135 of these RSUs vested on July 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Content

On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,135 of these RSUs vested on July 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.